Media

PolyMedix News

Mircrobe Magazine, December 2011
Mood at 2011 ICAAC Renewed Optimism Over Antimicrobial Prospects

Annual Life Sciences Awards, October 6, 2011
PolyMedix Selected as Best Mid-Stage Product Development Company

Genetic Engineering & Biotechnology News, May 9, 2011
Exploring New Ways to Get at Old Bacterial Targets to Combat Resistant Strains
While novel antibiotics are critically needed, some researchers say that there aren’t a whole lot of new bacterial targets to aim at. New antibiotics may mean enhancing old ones to evade bacterial resistance mechanisms.

Forbes, February 14, 2011 
Antibiotic Artisan
Using supercomputer simulations, chemist William DeGrado is crafting potent new drugs that mimic nature's own defenses.

The Suit, October 2010
Applying the Science of Nature to Antibiotics
Nicholas Landekic, CEO of PolyMedix Inc., has taken the road less traveled in the pharmaceutical business. After more than ten years working for big pharma and in research, he had earned a secure place in their workforce. 

LAtimes.com, September 27, 2010
New Ways to Fight Bacteria
Doctors and infectious bacteria are locked in an arms race.  In this ever-escelating battle, the bacteria evolve ways to avoid every drug humans throw at them. 

Genetic Engineering & Biotechnology News, December 1, 2009
Stanching the Action of Anticoagulants 
Critical need exists for heparin-reversal treatments with minimal side effects.

 Kimberly-Clark Professional, January 22, 2008
Novel Plastics Kill Bacteria on Contact
Most experts believe we are losing the war against disease-causing bacteria. Many are already resistant to antibiotics.